Literature DB >> 3050683

Linear IgA disease. The ocular manifestations.

E A Aultbrinker1, M B Starr, E D Donnenfeld.   

Abstract

The ocular history and examination of a 54-year-old Filipino woman with linear IgA disease is described. Results of the eye examination were consistent with chronic cicatricial conjunctivitis, showing subconjunctival fibrosis and symblepharon formation. Direct immunofluorescence of the conjunctiva was positive for IgA and C3 in a linear pattern along the epithelial basement membrane. The ophthalmologic and dermatologic findings in linear IgA disease are compared with those of dermatitis herpetiformis, bullous pemphigoid, and cicatricial pemphigoid. This is the first documented case report of the ocular manifestations of linear IgA disease in the American literature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050683     DOI: 10.1016/s0161-6420(88)33188-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

Review 1.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

Review 2.  [Classification of ocular surface disease. Part 1].

Authors:  F E Kruse; C Cursiefen; B Seitz; H E Völcker; G O H Naumann; L Holbach
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.174

3.  Ocular involvement and blindness secondary to linear IgA dermatosis.

Authors:  Cinthya Ramos-Castellón; Gabriela Ortiz-Nieva; Fernando Fresán; Leonardo Villalvazo; Yonathan Garfias; Alejandro Navas; María C Jiménez-Martínez
Journal:  J Ophthalmol       Date:  2010-12-22       Impact factor: 1.909

Review 4.  A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.

Authors:  Brendon W H Lee; Jeremy C K Tan; Melissa Radjenovic; Minas T Coroneo; Dedee F Murrell
Journal:  Orphanet J Rare Dis       Date:  2018-05-22       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.